Caristo Diagnostics
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
234 Botley Road, Oxford, Oxfordshire, OX...Phone Number
+44 1865950720Website
www.caristo.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Caristo Diagnostics
Founded in 2018, Caristo Diagnostics is an Oxford, UK-based biotechnology company which specializes in cardiac and vascular disease diagnostics and risk prediction.Explore more
Caristo Diagnostics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Caristo Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Caristo Diagnostics has new funding data
Website visits: Recent activity has been detected on your website
Caristo Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Caristo Diagnostics recently announced quarterly report
Check if Caristo Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Caristo Diagnostics had a recent Job posting/layoffs
Check out if Caristo Diagnostics is spiking on competitors!
Product Launch: Get notified when Caristo Diagnostics launches new products
Congratulate Masked Content for being promoted to Masked Content at Caristo Diagnostics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Caristo Diagnostics
Compare insights from companies similar to Caristo Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Caristo Diagnostics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Caristo Diagnostics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Caristo Diagnostics.
Caristo Diagnostics financials insights
Gather financial insights about Caristo Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$16.3M
Caristo Diagnostics Tech Stack
A closer look at the technologies used by Caristo Diagnostics
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Event
Product Marketing, Events, Sales, Search, Software, Doctors / Physicians, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Healthcare Technology, Operations
Caristo Diagnostics News & Media
Caristo Diagnostics' CaRi-Heart® Coronary Inflammation Technology Authorized by U.S. FDA
—First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management— —CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance— OXFORD, England and STAMFORD, Conn., July 29, 2026 /PRNewswire/ --...Steve Deitsch Joins Endologix's Board of Directors - Medical Product Outsourcing
Endologix names Caristo Diagnostics CEO Steve Deitsch to its board. He has more than a quarter century of relevant experience.Caristo Diagnostics Expands Executive Team, Naming David Vort Chief Commercial Officer and Chris Louk Chief Financial Officer
Appointments to scale adoption of Caristo's AI-powered cardiovascular technologies globally OXFORD, England and STAMFORD, Conn., July 23, 2026 /PRNewswire/ -- Caristo Diagnostics, a global leader in AI-powered technologies for cardiovascular disease, today announced two additions to its...Caristo Diagnostics to Highlight New Findings Reinforcing the Science of Its Coronary Inflammation and Plaque Analysis Technologies at SCCT 2026
Three of six SCCT 2026 Young Investigator Award-nominated abstracts utilize Caristo's technologies, including—for the first time—an application of FAI-Score on non-contrast cardiac CT OXFORD, England and STAMFORD, Conn., July 8, 2026 /PRNewswire/ -- Caristo Diagnostics, a global leader in...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Caristo Diagnostics
Sign Up For FreeTo access detailed company insights
Founded in 2018, Caristo Diagnostics is an Oxford, UK-based biotechnology company which specializes in cardiac and vascular disease diagnostics and risk prediction.... Read More
